Áreas terapeúticas

Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: A systematic review and network meta-analysis
^{Oykhman P, Paramo FA, Bousquet J, Kennedy DW, Brignardello-Petersen R, Chu DK. J Allergy Clin Immunol. 2022;149(4):1286-1295.}

Post-Marketing Surveillance of Tetravalent Diphtheria-Tetanus-Acellular Pertussis and Inactivated Poliovirus (DTaP-IPV) Vaccine in South Korea, 2009 to 2015
^{Choe YJ, et al. Infect Dis Ther. 2022 Aug;11(4):1479-1492.}

Dupilumab efficacy and safety in patients with asthma and blood eosinophils ≥500 cells·μL⁻¹

^{Rabe KF, Pavord ID, Castro M, et al. Eur Respir J. 2022; 59: 2102577}

Severe asthma in the US population and eligibility for mAb therapy
^{Akenroye A, McCormack M, Keet C. J Allergy Clin Immunol. 2020;145(4):1295-1297.e6.}

Outcome of Later-Onset Pompe Disease Identified Through Newborn Screening
^{Lee NC, Chang KL, In 't Groen SLM, de Faria DOS, Huang HJ, Pijnappel WWMP, Hwu WL, Chien YH. J Pediatr. 2022;244:139-147.}

Post-Marketing Safety Surveillance of a Childhood Pentavalent Diphtheria–Tetanus–Acellular Pertussis–Polio and Haemophilus influenzae Type B (DTaP-IPV//Hib) Vaccine in South Korea
^{Yang K, et al. Infect Dis Ther. 2022 Dec 15.}

Hepatitis B surface antigen prevalence and the rates of mother-to-child transmission of hepatitis B virus after the introduction of infant vaccination programs in South East Asia and Western Pacific regions: a systematic review
^{Marjenberg Z, et al. Int J Infect Dis. 2022 Nov;124:65-75}

Impact of a quadrivalent inactivated influenza vaccine on influenza associated complications and health care use in children aged 6 to 35 months: Analysis of data from a phase III trial in the Northern and Southern Hemispheres
^{Pepin S, et al. Vaccine. 2019 Mar 22;37(13):1885-1888.}

Immunogenicity of influenza vaccines administered to pregnant women in randomized clinical trials in Mali and South Africa
^{Amin AB, et al. Vaccine. 2020 Sep 22;38(41):6478-6483.}

Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in pregnant women: A randomized, observer-blind trial
^{Vesikari T, et al. Hum Vaccin Immunother. 2020 Mar 3;16(3):623-629.}

Influenza vaccination after myocardial infarction: A randomized, double-blind, placebo-controlled, multicenter trial
^{Fröbert O, et al. Circulation. 2021 Nov 2;144(18):1476-1484.}